MIRAMAR, Fla.--(BUSINESS WIRE)--Generex Biotechnology Corporation (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) (www.generex.com) today announced the following access information for its investor conference call, to be hosted by President & Chief Executive Officer Joseph Moscato, and his management team, tomorrow, Thursday, January 4, 2018, at 10:30 a.m. Eastern time:
|
Toll Free: |
1-877-888-4291 |
|||||||||||
|
Passcode: |
35411 |
The purpose of the conference call is to provide Company stockholders and other interested parties with an update in respect of the Company’s initiatives and strategic plans.